Carilion Clinic
Roanoke, Virginia, 24014, United States
NCT Number: NCT05397067
Hepatitis C Virus (HCV) infection is an ongoing challenge in the United States, with an estimated 2.4 million individuals living with HCV in 2016. According to the Virginia Department of Health, over 11,500 people were living with HCV infection in 2017 with a rate of 170 reported cases/100,000 adults. This study evaluated community-based interventions to improve linkage to care (LTC) among individuals with hepatitis C virus (HCV) infection and substance use disorders in Appalachia.
This study evaluated whether community-based interventions, including peer support, incentives, telehealth, and phone access, improve linkage to care among individuals with hepatitis C and substance use disorders in Appalachia.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Roanoke, Virginia, 24014, United States
This study evaluated community-based interventions to improve linkage to care (LTC) among individuals with hepatitis C virus (HCV) infection and substance use disorders in Appalachia.
The primary component of the study was a prospective interventional evaluation in which participants (N=60) were sequentially assigned to one of four cohorts: a control group and three intervention groups. All participants received peer support, with additional interventions introduced iteratively across cohorts, including incentive vouchers (e.g., food, transportation, phone), telehealth access, and provision of prepaid mobile phones to facilitate communication and engagement in care.
The primary outcome was attendance at the first HCV treatment visit.
The study used a pragmatic, quasi-experimental approach to evaluate the impact of these interventions on linkage to care. The goal was to assess whether addressing structural barriers such as transportation, communication access, and care navigation would improve engagement in HCV treatment among a high-risk population.
A qualitative component was conducted to inform intervention development and better understand barriers and facilitators to care. This included semi-structured interviews with patients and healthcare providers. Findings from the qualitative phase were used to refine intervention strategies but were not part of the interventional study population or quantitative outcome analyses.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
These participants will receive PRS support
These participants will receive incentives
These participants will receive telehealth visits
These participants will receive pre-paid phones
Time frame: Through study completion, within 6 months of diagnosis
Number of participants who attended their first hepatitis C treatment appointment following diagnosis. Results are reported by study phase (time-based arms)
Carilion Clinic
Other
Implementation of Low Cost Solutions to Help Facilitate Linkage to Care for Persons With Hepatitis C Virus Infection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04014179
Blood-Borne Infections, Chronic Disease
Bankstown, New South Wales, Australia
View Trial DetailsNCT00221650
Blood-Borne Infections, Chronic Disease
Bordeaux, France
View Trial DetailsNCT05904470
Blood-Borne Infections, Chronic Disease
San Antonio, Texas, United States
View Trial DetailsNCT01849562
Blood-Borne Infections, Chronic Disease
View Trial Details